Previous Article | Next Article 
Journal of Bacteriology, April 2003, p. 2259-2266, Vol. 185, No. 7
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.7.2259-2266.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
YscP and YscU Regulate Substrate Specificity of the Yersinia Type III Secretion System
Petra J. Edqvist,1 Jan Olsson,1 Moa Lavander,1,2 Lena Sundberg,1,2 Åke Forsberg,1,2 Hans Wolf-Watz,1 and Scott A. Lloyd1*
Department of Molecular Biology, Umeå University, S-90187 Umeå,1
Department of Microbiology, National Defense Research Agency, S-90182 Umeå, Sweden2
Received 3 July 2002/
Accepted 8 January 2003

ABSTRACT
Pathogenic
Yersinia species use a type III secretion system
to inhibit phagocytosis by eukaryotic cells. At 37°C, the
secretion system is assembled, forming a needle-like structure
on the bacterial cell surface. Upon eukaryotic cell contact,
six effector proteins, called Yops, are translocated into the
eukaryotic cell cytosol. Here, we show that a
yscP mutant exports
an increased amount of the needle component YscF to the bacterial
cell surface but is unable to efficiently secrete effector Yops.
Mutations in the cytoplasmic domain of the inner membrane protein
YscU suppress the
yscP phenotype by reducing the level of YscF
secretion and increasing the level of Yop secretion. These results
suggest that YscP and YscU coordinately regulate the substrate
specificity of the
Yersinia type III secretion system. Furthermore,
we show that YscP and YscU act upstream of the cell contact
sensor YopN as well as the inner gatekeeper LcrG in the pathway
of substrate export regulation. These results further strengthen
the strong evolutionary link between flagellar biosynthesis
and type III synthesis.

INTRODUCTION
There are three pathogenic species of
Yersinia:
Yersinia pestis,
Yersinia enterocolitica, and
Yersinia pseudotuberculosis. Yersinia pestis causes plague and is transmitted by flea bites or infectious
aerosols, while
Yersinia enterocolitica and
Yersinia pseudotuberculosis are enteric pathogens that cause gastroenteritis after the ingestion
of contaminated food or water (for reviews, see references
3 and
36). After reaching the intestine, enteropathogenic
Yersinia cells are taken up by antigen-sampling M cells (
1). This enables
the bacteria to colonize the Peyer's patches, a gut-associated
lymphoid tissue. Once in the Peyer's patches, the bacteria are
able to inhibit phagocytosis by macrophages (
10,
38) and polymorphonuclear
leukocytes (
52), which allows them to replicate extracellularly
(
44). In humans, such infections are typically self-limiting,
while in rodents, the bacteria are able to colonize other organs,
which results in a deadly systemic infection. The ability to
cause infection is dependent on the presence of an approximately
70-kb plasmid encoding a type III secretion system (TTSS) that
delivers Yop effectors into the cytosol of the target cell.
The
Yersinia TTSS is comprised of about 25 Ysc (Yop secretion)
proteins. Nine of these proteins are conserved in the bacterial
flagellar export apparatus and in the TTSSs found in a wide
variety of gram-negative plant and animal pathogens (for a review,
see reference
19). The
Yersinia type III secretion apparatus
assembles a needle-like structure comprised of the YscF protein
on the bacterial cell surface prior to eukaryotic cell contact
(
18). The TTSSs of other gram-negative pathogens form similar
structures (
7,
21,
22,
48,
49). The concept of substrate specificity
switching by TTSSs was first demonstrated in the flagellar system.
The bacterial flagellum consists of three parts: the basal body,
which is located in the cell wall and membranes of the bacterium;
the hook, which is located on the cell surface; and the long
flagellar filament, which is assembled onto the end of the hook
and serves as a propeller during bacterial motility (for a review,
see reference
26). The length of the hook is normally 55 nm.
Yamaguchi and colleagues, however, showed that a
fliK mutant
exhibits a polyhook phenotype in which hook elongation proceeds
to an abnormal extent but no flagellar filament is built (
34).
Mutations in
fliK can be suppressed, with respect to filament
assembly, by mutations in the export apparatus protein FlhB
(
24,
51), which is located in the bacterial inner membrane.
Work by Minamino and Macnab has demonstrated that FliK, along
with the hook and filament proteins, binds to the cytoplasmic
domain of FlhB (
30,
31). Therefore, upon the completion of hook
assembly, it is possible that FliK switches the substrate specificity
of the flagellar export apparatus by altering the conformation
of FlhB in order to promote the export of the filament component
flagellin. A similar phenomenon has been reported in the TTSS
encoded by
Salmonella pathogenicity island 1 (SPI1). Specifically,
an
invJ mutant assembles a type III secreton with abnormally
long needles (
23). Interestingly, an
invJ mutant is unable to
secrete effector proteins (
5), which suggests that it is defective
in substrate specificity switching. Recent findings by Tamano
and coworkers (
49) showed that Spa32 of
Shigella spp. is involved
in the control of needle length. Spa32 is homologous to InvJ
and, interestingly, Spa32 is interchangeable with InvJ of
Salmonella (
49).
Here, we examined the phenotype of yscP mutants of the Yersinia TTSS. We demonstrate that a yscP mutant exports an increased amount of YscF to the bacterial cell surface prior to eukaryotic cell contact. Furthermore, the yscP mutant is able to secrete only low levels of the translocator proteins, YopB and YopD, and Yop effectors. Mutations in the cytoplasmic domain of the inner membrane protein YscU can restore a level of Yop effector secretion to the yscP mutant higher than that to the corresponding isogenic wild-type strain, while the amount of YscF present on the bacterial cell surface is reduced. These results suggest that YscP and YscU coordinately regulate secretion of the Yersinia TTSS.

MATERIALS AND METHODS
Media and growth conditions.
Yersinia strains were grown in brain-heart infusion (BHI) broth
supplemented with either 5 mM EGTA and 20 mM MgCl
2 (BHI minus
Ca
2+) or 2.5 mM CaCl
2 (BHI plus Ca
2+).
Escherichia coli strains
were grown in Luria-Bertani broth (LB) (
8).
Yersinia strains
were grown in LB containing 50 µg of kanamycin ml
-1 to
maintain selection of the virulence plasmid.
Yersinia strains
carrying YscU-expressing plasmids were grown in LB supplemented
with 100 µg of carbenicillin ml
-1.
DNA methods.
DNA preparations and routine subcloning were performed as described by Sambrook et al. (42). DNA-sequencing reactions were performed by using the ThermoSequenase dye terminator cycle sequencing kit and analyzed with a SEQ4 x 4 sequencer (Amersham Pharmacia Biotech).
Construction of a yscF in-frame deletion mutant.
PCR was performed with the primer pairs YscF3-YscF4 and YscF5-YscF6, respectively, by using the plasmid pIB102 as template. YscF3 was tailed with an XbaI site, and YscF6 was tailed with a SacI site. The PCR yielded one fragment from the upstream region and one fragment from the downstream region of yscF. The 5' ends of the primers YscF4 and YscF5 contain overlapping sequences between the two fragments, and a second PCR with the two fragments as templates and the primers YscF3 and YscF6 resulted in a fragment in which the yscF gene, deleted for codons 11 through 69, was flanked by upstream and downstream sequences. After digestion with XbaI and SacI, the fragment was cloned into the vector pDM4 (Table 1), resulting in pLS52. This plasmid was transformed into E. coli strain S17-1
pir, clones were selected on plates containing chloramphenicol, and the resulting transformants were verified by PCR. E. coli containing the plasmid was then used to introduce pLS52 by conjugation into the recipient Yersinia strain YPIII(pIB102). Clones in which the plasmid integrated by a single recombination event were selected on Yersinia selective agar base (YSAB) plates containing 50 µg of kanamycin/ml and 20 µg of chloramphenicol/ml. The insertion was verified by PCR with the primers from the second PCR. The resulting strain was then counterselected on sucrose to select for clones that had lost the plasmid. The yscF deletion was verified by PCR with primers YscF3 and YscF6. The resulting mutant was denoted YPIII(pIB202).
For transcomplementation studies, the
yscF gene was amplified
by PCR with the primers YscF1 and YscF2 tailed with sites for
EcoRI and
PstI and cloned into the vector pMMB66EH in the strain
E. coli S17-1

pir. After conjugation into the mutant strain on
YSAB plates containing 100 µg of carbenicillin/ml and
50 µg of kanamycin/ml, the plasmid (pLS53) was verified
by a plasmid mini preparation and PCR with the same primer pair.
The primers used and their sequences were as follows: YscF1,
5'-GCT CAG AAT TCG ATG AGT AAC TTC TCT GGA TTT A-3' (bp 4193
through 4214); YscF2, 5'-CTG ACT CTG CAG TTC ATA TTA TGG GAA
CTT CTG T-3' (bp 4462 through 4441); YscF3, 5'-GCT GA
T CTA GAC
GAA TTG AAT TTC GAG GTG CAA G-3' bp 3801 through 3822); YscF4,
5'-GAT GCC TTG TCC TTT CGT AAA TCC AGA GAA G-3' (bp 4222 through
4201); YscF5, 5'-ACG AAA GGA CAA GGC ATC CTA CAG AAG TTC-3'
(bp 4430 through 4450); YscF6, 5'-GCT CAC
GAG CTC GAG ACG ATT
TAA ACG TGA CTC-3' (bp 4739 through 4719). All YscF primer sequences
were from GenBank under accession no.
M83225. Restriction sites
are shown in boldface.
Construction of the yscP-null strain.
An in-frame deletion was made in the yscP gene by PCR amplifying YPIII(pIB102) genomic DNA with Pfx DNA polymerase and the primer pairs SL89-SL90 (which resulted in a fragment complementary to the upstream gene yscO and the first six codons of the yscP gene) and SL91-SL92 (which resulted in a fragment complementary to the last six codons of the yscP gene and the downstream gene yscQ). The two fragments were ligated by PCR with the primer pair SL89-SL92. The resulting PCR product was digested with XbaI and SphI and cloned into the same sites in the suicide vector pDM4. The resulting construct, pSL144, was then transformed into the E. coli strain S17-1
pir (43) and conjugated into the wild-type Yersinia strain YPIII(pIB102) by plating on Yersinia agar (Difco) plates containing 25 µg of chloramphenicol ml-1. Exconjugants were restreaked onto LB plates containing 5% sucrose in order to counterselect against bacteria still containing the pSL144 plasmid. Sucrose-resistant colonies were PCR amplified with the primer pair SL89-SL92 to confirm the presence of the deletion. The resulting strain, YPIII(pIB69), lacked codons 7 through 449 of the yscP gene. The primers used and their sequences were as follows: SL89, 5'-GCC TCT AGA TCA GCA AGC TTG CTT GCA GGC; SL90, 5'-CTC CCA CTC CTC ATA CTC AGG TTC TAA TGG GGA; SL91, 5'-GAA CCT GAG TAT GAG GAG TGG GAG GCT GAA GAA; SL92, 5'-GGC GCA TGC CCA GAA GGA GAT ATG CGC ATT. Restriction sites are shown in boldface.
Construction of the yscP yopB-double-null strain.
Plasmid pSL144 was conjugated into the yopB-null strain YPIII(pIB604) (19) as described above. The resulting strain was the yscP yopB-double-null strain YPIII(pIB60469).
Construction of the yscP yscU-double-null strain.
Plasmid pSL144 was conjugated into the yscU-null strain YPIII(pIB75) as described above.
Construction of the yopN yscP-double-null strain.
An in-frame deletion in the yopN gene was constructed by PCR amplifying YPIII(pIB102) genomic DNA with Pfx DNA polymerase and the primer pairs SAL226-SAL227 (which resulted in a fragment complementary to the yopN promoter region and the first six codons of the yopN coding sequence) and SAL228-SAL229 (which resulted in a fragment complementary to the last four codons of the yopN gene and the downstream gene tyeA). The two fragments were ligated by PCR with the primer pair SAL226-SAL229. The resulting PCR product was digested with SphI and XbaI and cloned into the same sites of the suicide vector pDM4. The resulting construct, pSL340, was conjugated into the yscP-null strain YPIII(pIB69) as described above. The resulting strain, YPIII(pIB8769), lacked codons 7 through 289 of the yopN gene. The primers used and their sequences were as follows: SAL226, 5'-GCC GCA TGC GGC GGC TAC CTA CAA TGC CAT GAC; SAL227, 5'-GAA AGG TCG TAC GTT ATG AAG CGT CGT CAT AAC TAC; SAL228, 5'-ACG CTT CAT AAC GTA CGA CCT TTC TGA GTT TAT GGG; SAL229, 5'-GGC TCT AGA GCC AGA TTG AGC CAT CTC TAA TTG. Restriction sites are shown in boldface.
Preparation of YscF antiserum.
A fragment of yscF generated by PCR with primer pair JO214-JO217 and strain YPIII(pIB102) as template was cloned into pGEX-5X-3 (Amersham Pharmacia Biotech) with the BamHI and NotI restriction sites, generating plasmid pJO33. Fusion proteins were expressed, purified, and cleaved at the factor Xa cleavage site according to the manufacturer's instructions. The resulting polypeptide, approximately 8 kDa in size, was used as antigen to raise a polyclonal rabbit antiserum (Agrisera, Umeå, Sweden), which was used in Western blots without further purification. The primers used were JO214 (5'-CG ACA GGG ATC CAG ATG AGT AAC TTC TCT GGA TTT) and JO217 (5'-CGA CAG GCG GCC GCG TTA TGG GAA CTT CTG TAG GA). Restriction sites are shown in boldface.
Construction of mutations in the cytoplasmic domain of YscU.
YPIII(pIB102) genomic DNA was PCR amplified with Pfx DNA polymerase and the primer pair SL53-SL83. The resulting PCR product, consisting of the yscU gene, was digested with EcoRI and PstI and cloned into the same sites in the pKK223-3 vector (Amersham Pharmacia Biotech) such that the expression of YscU was under the control of the isopropyl-ß-D-thiogalactopyranoside (IPTG)-inducible tac promoter. The resulting construct, pPE33, was used as the template for site-directed mutagenesis, which was carried out according to the procedures in the GeneEditor in vitro site-directed mutagenesis kit (Promega).
The mutagenic oligonucleotides used were as follows: the A268F mutation (PE40), the Y287G mutation (PE41), the V292T mutation (PE43), and the Y317D mutation (PE46). The primers used and their sequences were as follows: SL53, 5'-GGC CTG CAG TTA TAA CAT TTC GGA ATG TTG; SL83, 5'-GCC GAA TTC ATG AGC GGA GAA AAG ACA GAG; PE40, 5'-CCG ACC CAT ATT TTC ATT GGT ATT CTT TAC; PE41, 5'-GTA ACA TTC AAA GGT ACC GAT GCC CAA G; PE43, 5'-ACC GAT GCC CAA ACT CAG ACT GTG CGC; PE46, 5'-GCC CGT GCT CTT GAT TGG GAT GCG CTC G. Restriction sites are depicted in boldface.
Yop secretion assay.
Overnight cultures of Y. pseudotuberculosis strains were grown in BHI medium lacking Ca2+ which contained 50 µg of kanamycin ml-1 at 26°C. The cultures were diluted to an optical density at 600 nm of 0.2 into 10 ml of fresh medium and grown at 26°C for 1 h and then for an additional 2 h at 37°C to induce secretion. The cultures were then centrifuged at 3,000 x g for 15 min. The supernatants containing the secreted Yops were passed through a 0.45-µm-pore-size filter and precipitated with 10% trichloroacetic acid (TCA). TCA precipitates were centrifuged at 3,000 x g for 20 min, the supernatants were discarded, and the remaining pellets were dried at room temperature. The pellets were resuspended in 250 µl of 2% sodium dodecyl sulfate (SDS) and precipitated with acetone at -20°C for 30 min. Samples were centrifuged at 20,800 x g for 10 min, the supernatants were discarded, and the pellets were air-dried. The pellets were then resuspended in 100 µl of 8 M urea and an equal amount of 2x sample buffer. Equal amounts of culture supernatant and cell pellet fractions were separated by SDS-PAGE gels stained with Coomassie blue or transferred to a nitrocellulose membrane. Yop proteins were detected by using a polyclonal anti-Yop antiserum raised against cell-secreted Yops (11).
Immunoblotting.
Samples were separated by SDS-12% PAGE and electroblotted (Trans Blot SD; Bio-Rad) onto a nitrocellulose transfer membrane (Protran; Schleicher and Schuell) by using a transfer buffer containing 25 mM Tris, 192 mM glycine, and 20% methanol. The membrane was blocked for 1 h with Tris-buffered saline plus 0.1% Tween 20 (TBS-T) and 5% nonfat dry milk. The membrane was probed for 1 h with the appropriate polyclonal antiserum in 10 ml of the blocking buffer and was then washed three times at 5 min each with TBS-T. The membrane was incubated for 1 h with an anti-rabbit antibody (Amersham Pharmacia Biotech) in 10 ml of blocking buffer, followed by washing with TBS-T. Proteins were detected by using an enhanced chemiluminescence detection kit (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Surface localization of YscF.
Overnight cultures of the wild-type Y. pseudotuberculosis strain YPIII(pIB102), the yscF-null mutant YPIII(pIB202), and the yscP-null mutant YPIII(pIB69), expressing different YscU constructs, were grown at 26°C in BHI medium containing calcium (2.5 mM) supplemented with 50 µg of kanamycin ml-1 (to select for the virulence plasmid) and 100 µg of carbenicillin ml-1 (to select for YscU-expressing constructs). The cultures were diluted to an optical density at 600 nm of 0.2 in 10 ml of fresh medium and grown for 1 h at 26°C, after which the cultures were shifted to 37°C for 2 h to induce secretion. Whole cultures were sheared by five passages through a hypodermic needle (23Gx1, 0.6 by 25 mm; B. Braun), which released surface proteins and organelles from the bacterial surface. The cultures were centrifuged at 1,800 x g for 15 min. The pellets were resuspended in 100 µl of H2O and an equal amount of 2x sample buffer. The supernatants were precipitated with 10% TCA and incubated on ice for 30 min and thereafter centrifuged at 1,800 x g for 20 min. Next, the supernatants were discarded and the pellets were resuspended in 250 µl of 2% SDS and precipitated with acetone at -20°C for 30 min. The samples were then centrifuged at 15,000 x g for 10 min, the supernatants were discarded, and the pellets were dried, followed by resuspension in 100 µl of 8 M urea and an equal amount of 2x sample buffer. Two microliters of the pellet, diluted 1:10, and 5 µl of undiluted supernatant were separated by 15% Tris-tricine SDS-PAGE and transferred to a nitrocellulose membrane. YscF was detected with a polyclonal anti-YscF antibody.
Cytotoxicity assay.
Overnight cultures of the wild-type strain YPIII(pIB102), the yscP-null mutant YPIII(pIB69), and the yopB yscP-double-null mutant YPIII(pIB60469) were grown in LB containing 50 µgof kanamycin ml-1; for strains expressing different YscU constructs, 100 µg of carbenicillin ml-1 was also added. Cytotoxicity was assayed as described previously (39). Pictures were taken with a phase-contrast microscope (Zeiss).

RESULTS
Phenotypic characterization of a yscP mutant.
To investigate the possible role of YscP in regulating the secretion
of the
Yersinia type III needle protein YscF, a
yscP-null mutant,
YPIII(pIB69), and the isogenic wild-type strain YPIII(pIB102)
(Table
1) were grown at 37°C in either the presence or absence
of calcium. The bacterial supernatants were first investigated
for the presence of YscF. No YscF could be detected in these
fractions, showing that YscF was not released to the culture
medium during growth (data not shown). The bacterial pellets
were sheared to release surface proteins and organelles from
the bacterial surface. When the sheared fraction of the bacterial
pellet was investigated, the
yscP-null mutant was found to release
larger amounts of YscF to the bacterial surface than the wild-type
strain, irrespective of the calcium concentration of the medium
(Fig.
1A). Since no YscF was found in the culture supernatants,
we concluded that the YscF protein recovered from the sheared
fractions originated from the bacterial surface. In addition,
the levels of YscF in the bacterial pellets recovered after
shearing were similar (Fig.
1A), which suggested that the increased
level of YscF released by shearing that was found in the
yscP-null
mutant was not due to increased expression of the YscF protein.
Moreover, we could also confirm the findings of others that
the
yscP mutant secreted much lower levels of Yops than the
wild-type strain (Fig.
1B) (
35,
46).
YopE is a Rho-GTPase-activating protein (
53) that, when translocated
into the eukaryotic cell cytosol, induces a cytotoxic effect
by disrupting the actin cytoskeleton of host cells (
40). Since
the
yscP mutant was defective in Yop secretion, we tested whether
it was capable of inducing a cytotoxic response in eukaryotic
cells. HeLa cells were infected with either the
yscP mutant
YPIII(pIB69) or the wild-type strain YPIII(pIB102), and cytotoxicity
was monitored by phase-contrast microscopy (Fig.
2). The results
demonstrate that, consistent with the
yscP mutant's defect in
Yop secretion, the cytotoxic effect induced by the
yscP mutant
was delayed relative to that induced by the wild-type strain.
The control strain, a
yscP yopB double mutant which lacks the
essential translocator protein YopB (
16,
33,
45), did not induce
a cytotoxic response. These results suggest that YscP is not
required for the translocation of effector proteins into the
cytosols of eukaryotic cells but rather exerts its effect at
the level of Yop secretion.
Mutations in YscU partly suppress the yscP mutant phenotype.
Previous studies demonstrated that a
fliK mutant, which exhibits
a polyhook phenotype, could be partially suppressed by mutations
in the cytoplasmic domain of the inner membrane protein FlhB
(
24,
51). Homologues of FlhB are essential components of all
TTSSs (for a review, see reference
19), and the
Yersinia FlhB
homologue is YscU. Guided by the suppressor mutations isolated
by Macnab and colleagues, we used site-directed mutagenesis
to introduce four individual missense mutations into the cytoplasmic
domain of YscU (Fig.
3A). The mutations included the following:
A268F(pPE36), Y287G(pPE37), V292T(pPE38), and Y317D(pPE39).
The YscU mutants were first expressed in
trans under the control
of the IPTG-inducible
tac promoter in the
yscU-null strain YPIII(pIB75).
Bacteria were grown at 37°C in the absence of calcium in
order to induce Yop secretion. The results show that the level
of Yop secretion by the A268F and V292T mutants was equivalent
to that of wild-type YscU, while the Y317D mutant secreted much
lower levels of Yop (Fig.
3B). The Y287G mutant secreted Yops
at an intermediate level (Fig.
3B).
Each of the YscU mutants was then expressed in the
yscP yscU-double-null
mutant to investigate whether it could partially suppress the
yscP phenotype in comparison with FlhB. Bacteria were grown
at 37°C in medium lacking calcium, and Yop secretion was
measured. The results indicate that all the YscU mutants restored
an increased level of Yop secretion when expressed in the
yscP yscU double mutant compared to wild-type YscU (Fig.
4A). Consistent
with these results, these same
yscU mutants also restored a
more rapid cytotoxic response to the
yscP yscU strain (Fig.
4B). Thus, these
yscU mutants could suppress the
yscP mutation
and, similar to the corresponding
flhB mutants, the suppression
was only partial. Next, the surface localization of YscF was
examined. Bacteria were grown at 37°C in calcium-containing
medium and sheared to release surface-located proteins. The
results showed that expression of both YscU-Y287G and YscU-Y317D
reduced the amount of surface-localized YscF in the
yscP yscU double mutant, whereas the other YscU mutations did not (Fig.
4C). The YscU-Y317D suppressor mutation exhibited the strongest
suppressor phenotype with respect to both Yop and YscF secretion
(compare Fig.
3 with
4A and C). Together, these results confirmed
that mutations in YscU can suppress the phenotype of the
yscP-null
mutant, which strongly argues for the fact that YscP and YscU
coordinately regulate substrate export by the
Yersinia TTSS.
YscP acts upstream of YopN, LcrG, LcrQ, and YopD.
Previous studies indicated that the LcrG (
9,
27,
32) and YopN
(
4,
12) proteins might act as stop valves or gatekeepers to
inhibit Yop secretion prior to eukaryotic cell contact. This
is based on the fact that mutations in any of these genes result
in a calcium-blind derepressed phenotype in which Yops are secreted
in the presence of calcium. To determine the order in which
YscP, YscU, and YopN act during the regulation of substrate
export by the
Yersinia TTSS, we constructed a
yopN yscP double
mutant. This strain was grown at 37°C in either the presence
or absence of calcium, and Yop secretion was measured. The results
showed that Yop secretion was impaired in both the presence
and absence of calcium (Fig.
5A). The amount of the needle component
YscF exported to the bacterial cell surface by the
yopN yscP-null
strain was also examined. Bacteria were grown at 37°C in
the presence of calcium and were sheared to release YscF from
the bacterial cell surface. The results showed that the
yopN yscP strain exported an abnormally large amount of YscF to the
bacterial cell surface (Fig.
5B). The fact that the phenotype
of the
yopN yscP double mutant is similar to that of the
yscP mutant alone, with regards to the levels of YscF and Yop secretion,
indicates that YopN did not directly regulate the substrate
specificity of the
Yersinia TTSS but rather acted downstream
of YscP and YscU to regulate substrate export in response to
eukaryotic cell contact.
LcrG has been suggested to act as an inner gatekeeper, working
at the cytosolic side to regulate substrate export via the TTSS
(
32), and a
lcrG mutant expresses and secretes Yops also in
the presence of Ca
2+. An interesting question was whether LcrG
acted upstream or downstream of YscP in the regulatory hierarchy.
Therefore, a double
lcrG yscP mutant was constructed and analyzed.
In comparison with the
yopN yscP double mutant, the
lcrG yscP mutant did not secrete Yops but instead exported YscF in large
amounts to the surface of the cell (data not shown). Thus, YscP
and YscU are epistatic over LcrG.
Two additional proteins, LcrQ and YopD, have also been implicated in Yop regulation, since the corresponding mutants in contrast to the wild-type strain showed high levels of Yop expression when incubated at 37°C in the presence of Ca2+ (13, 37, 50). We wanted to investigate the possibility that these two proteins affected the YscP-YscU substrate switch. Therefore, we analyzed the phenotypes of the lcrQ yscP and yopD yscP double mutants. Both double mutants had lost their ability to secrete Yops but had retained their ability to secrete YscF in large amounts to the bacterial surface (data not shown), indicating that neither LcrQ nor YopD affects the substrate specificity switch of the Yersinia TTSS.

DISCUSSION
In this work, we have confirmed and extended previous findings
regarding the role of YscP in the TTSS by
Yersinia (
35,
46)
and shown that
yscP-null mutants were severely affected in their
ability to secrete Yop effector proteins. In contrast, the YscF
protein was secreted in elevated amounts. YscF subunits build
up a surface-located pilus-like structure, the needle structure,
which protrudes from the
Yersinia TTSS (
18). Similar structures
have also been identified in
Salmonella and in
Shigella (
21,
22,
49). YscP shows homology to InvJ of
Salmonella and Spa32
of
Shigella. Mutants in either
invJ or
spa32 assemble extended
needles, and these mutants are also unable to secrete effector
molecules to the culture supernatant (
23,
49). Thus,
yscP-null
mutants show a phenotype similar to that of the
invJ and
spa32 mutants, indicating that YscP, InvJ, and Spa32 exhibit similar
functions in regulating the secretion of effector proteins in
the three different species. Work by Kutsukake, Macnab, and
coworkers has shown that FliK, which is essential for regulating
the hook length of the flagellum, is involved in regulating
the subunit secretion of the flagellum export apparatus (
24,
51). Interestingly, FliK shows homology with YscP, InvJ, and
Spa32 (
19), and Galan and coworkers have suggested that InvJ
is, in comparison to FliK, involved in regulating substrate
specificity (
23). Our findings support this view, and we suggest
that YscP has a similar function by regulating a switch in secretion
from YscF to Yop effectors after the TTSS has been activated
by eukaryotic cell contact. How this switch is regulated is
at present unclear. Our results show, however, that the inactivation
of YscP results in elevated YscF secretion and reduced Yop secretion.
This suggests that YscP is inactive prior to contact between
the pathogen and the eukaryotic cell. Consequently, YscP is
activated upon target cell contact, which results in elevated
Yop secretion and subsequent Yop translocation. A potential
problem with this model is the fact that YscP is secreted (unpublished
results) (
35,
46). However, both InvJ and FliK are secreted,
and it seems therefore likely that these proteins fulfill their
regulatory functions prior to or during secretion and that secretion
per se is not a prerequisite for their function (
6,
29). The
yscP-null mutant shows a leaky phenotype with regards to Yop
secretion, since the mutant is still cytotoxic for HeLa cells.
This is in contrast to
fliK flagellar mutants and
invJ mutants
of
Salmonella, which are impaired in substrate secretion (
41,
51). The reason behind this difference is unclear, but it is
possible that our cytotoxic assay was more sensitive than the
assays used to determine the phenotypes of the
fliK and
invJ mutants. Another possibility is that the other type III systems
of
Yersinia encoded by chromosomal genes can partially complement
the loss of secretion by a
yscP-null mutant and thus cause an
artificial situation.
Interestingly, Kutsukake, Macnab, and coworkers have isolated suppressor mutants that partially restore the fliK phenotype with regards to filament assembly. These extragenic suppressors were localized to flhB and were found to be substitutions in the carboxy-terminal end of FlhB (Fig. 3A) (24, 51). FlhB is homologous to YscU of Yersinia, and when the corresponding amino acids were changed in YscU, partial suppression of the yscP-null mutant was obtained. This was evidenced by an increased level of Yop secretion in vitro and by the induction of a more rapid cytotoxic response in infected HeLa cells in vivo. The suppression of the yscP mutant phenotype by the YscU-Y317D mutant was particularly impressive given that this mutant secreted much lower levels of Yop than wild-type YscU when expressed in the yscU-null strain (compare Fig. 3B with 4A). In addition, the YscU-A268F and YscU-Y317D mutations reduced the amount of YscF present on the bacterial surface in a calcium-containing medium. Given that most of the mutations in YscU involve the replacement of hydrophobic residues with polar residues or larger hydrophobic residues, we suspect that these mutant proteins may have slightly altered conformations that serve to mimic the conformation of YscU that normally occurs when YscP is present. In any event, this suppression suggests that YscU, together with YscP, has a role in regulating the secretion of Yop effectors as well as YscF in the Yersinia TTSS. Like FlhB (30), the C-terminal cytoplasmic part of YscU is organized into two domains, as it was demonstrated that YscU was specifically proteolyzed in vivo (25). Although there is no evidence that the proteolysis of YscU per se is important for the function of the Yersinia TTSS, it clearly reflects the conformation of the YscU cytoplasmic domains. Specifically, deletion of the conserved proteolytic site of YscU, comprised of amino acid residues 263 through 266, did not abolish the proteolysis of YscU but resulted in a larger C-terminal proteolytic fragment. This result is consistent with the YscU-
263-266 mutant having an altered conformation (25). Significantly, this mutant restored only minimal Yop secretion to the yscU-null strain, which suggests that the conformation of the cytoplasmic domains of YscU is important for Yop secretion (25). Since YscP and YscU coordinately regulate secretion by the Yersinia TTSS, we suggest that YscP may serve to regulate the conformation of YscU in the cytosol of the bacterial cell.
It has been suggested that the LcrG (9, 27, 32) and YopN (4, 12, 20) proteins function as gatekeepers to prevent Yop effector secretion prior to eukaryotic cell contact. Specifically, these mutants display a calcium-independent phenotype in which Yop secretion occurs, even when the bacteria are grown in a medium that contains calcium. LcrG is thought to act intracellularly (9, 27, 32), while YopN (12) is thought to act on the bacterial cell surface. The question is whether these proteins act downstream of YscP and YscU or whether they have a direct role in regulating the substrate specificity of the Yersinia TTSS. Our results showed that both a yopN yscP and a lcrG yscP double mutant exhibit a phenotype essentially the same as that of the yscP mutant alone. That is, the double mutants exported an increased amount of the needle component YscF to the bacterial cell surface in the presence of calcium but were unable to efficiently secrete Yops in either the presence or absence of calcium. These results suggest that YopN and LcrG act downstream of YscP and YscU. Thus, these proteins may serve as a safety mechanism to prevent the premature secretion of Yop effectors until eukaryotic cell contact occurs.

ACKNOWLEDGMENTS
This work was supported by the Swedish Research Council and
the Swedish Foundation of Strategic Research.

FOOTNOTES
* Corresponding author. Present address: Center for Vaccine Development, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201. Phone: (410) 706-7376. Fax: (410) 706-6205. E-mail:
scottlloyd23{at}hotmail.com.


REFERENCES
1 - Autenrieth, I. B., and R. Firsching. 1996. Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study. J. Med. Microbiol. 44:285-294.[Abstract/Free Full Text]
2 - Bölin, I., L. Norlander, and H. Wolf-Watz. 1982. Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect. Immun. 37:506-512.[Abstract/Free Full Text]
3 - Brubaker, R. R. 1991. Factors promoting acute and chronic diseases caused by yersiniae. Clin. Microbiol. Rev. 4:309-324.[Abstract/Free Full Text]
4 - Cheng, L. W., O. Kay, and O. Schneewind. 2001. Regulated secretion of YopN by the type III machinery of Yersinia enterocolitica. J. Bacteriol. 183:5293-5301.[Abstract/Free Full Text]
5 - Collazo, C. M., and J. E. Galan. 1996. Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella typhimurium. Infect. Immun. 64:3524-3531.[Abstract]
6 - Collazo, C. M., M. K. Zierler, and J. E. Galan. 1995. Functional analysis of the Salmonella typhimurium invasion genes invl and invJ and identification of a target of the protein secretion apparatus encoded in the inv locus. Mol. Microbiol. 15:25-38.[Medline]
7 - Daniell, S. J., N. Takahashi, R. Wilson, D. Friedberg, I. Rosenshine, F. P. Booy, R. K. Shaw, S. Knutton, G. Frankel, and S. Aizawa. 2001. The filamentous type III secretion translocon of enteropathogenic Escherichia coli. Cell. Microbiol. 3:865-871.[CrossRef][Medline]
8 - Davis, R. W., D. Botstein, J. R. Roth, and the Cold Spring Harbor Laboratory. 1980. Advanced bacterial genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
9 - DeBord, K. L., V. T. Lee, and O. Schneewind. 2001. Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica. J. Bacteriol. 183:4588-4598.[Abstract/Free Full Text]
10 - Fällman, M., K. Andersson, S. Håkansson, K. E. Magnusson, O. Stendahl, and H. Wolf-Watz. 1995. Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infect. Immun. 63:3117-3124.[Abstract]
11 - Forsberg, A., I. Bölin, L. Norlander, and H. Wolf-Watz. 1987. Molecular cloning and expression of calcium-regulated, plasmid-encoded proteins of Y. pseudotuberculosis. Microb. Pathog. 2:123-137.[CrossRef][Medline]
12 - Forsberg, A., A. M. Viitanen, M. Skurnik, and H. Wolf-Watz. 1991. The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol. Microbiol. 5:977-986.[Medline]
13 - Francis, M. S., and H. Wolf-Watz. 1998. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation. Mol. Microbiol. 29:799-813.[CrossRef][Medline]
14 - Fürste, J. P., W. Pansegrau, R. Frank, H. Blocker, P. Scholz, M. Bagdasarian, and E. Lanka. 1986. Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48:119-131.[CrossRef][Medline]
15 - Guzman, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121-4130.[Abstract/Free Full Text]
16 - Håkansson, S., K. Schesser, C. Persson, E. E. Galyov, R. Rosqvist, F. Homble, and H. Wolf-Watz. 1996. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15:5812-5823.[Medline]
17 - Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.[Medline]
18 - Hoiczyk, E., and G. Blobel. 2001. Polymerization of a single protein of the pathogen Yersinia enterocolitica into needles punctures eukaryotic cells. Proc. Natl. Acad. Sci. USA 98:4669-4674.[Abstract/Free Full Text]
19 - Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.[Abstract/Free Full Text]
20 - Iriarte, M., M. P. Sory, A. Boland, A. P. Boyd, S. D. Mills, I. Lambermont, and G. R. Cornelis. 1998. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors. EMBO J. 17:1907-1918.[CrossRef][Medline]
21 - Kimbrough, T. G., and S. I. Miller. 2000. Contribution of Salmonella typhimurium type III secretion components to needle complex formation. Proc. Natl. Acad. Sci. USA 97:11008-11013.[Abstract/Free Full Text]
22 - Kubori, T., Y. Matsushima, D. Nakamura, J. Uralil, M. Lara-Tejero, A. Sukhan, J. E. Galan, and S. I. Aizawa. 1998. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280:602-605.[Abstract/Free Full Text]
23 - Kubori, T., A. Sukhan, S. I. Aizawa, and J. E. Galan. 2000. Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc. Natl. Acad. Sci. USA 97:10225-10230.[Abstract/Free Full Text]
24 - Kutsukake, K., T. Minamino, and T. Yokoseki. 1994. Isolation and characterization of FliK-independent flagellation mutants from Salmonella typhimurium. J. Bacteriol. 176:7625-7629.[Abstract/Free Full Text]
25 - Lavander, M., L. Sundberg, P. J. Edqvist, S. A. Lloyd, H. Wolf-Watz, and A. Forsberg. 2002. Proteolytic cleavage of the FlhB homologue YscU of Yersinia pseudotuberculosis is essential for bacterial survival but not for type III secretion. J. Bacteriol. 184:4500-4509.[Abstract/Free Full Text]
26 - Macnab, R. M. 1996. Flagella and motility, p. 123-145. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
27 - Matson, J. S., and M. L. Nilles. 2001. LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. J. Bacteriol. 183:5082-5091.[Abstract/Free Full Text]
28 - Milton, D. L., R. O'Toole, P. Horstedt, and H. Wolf-Watz. 1996. Flagellin A is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 178:1310-1319.[Abstract/Free Full Text]
29 - Minamino, T., B. Gonzalez-Pedrajo, K. Yamaguchi, S. I. Aizawa, and R. M. Macnab. 1999. FliK, the protein responsible for flagellar hook length control in Salmonella, is exported during hook assembly. Mol. Microbiol. 34:295-304.[CrossRef][Medline]
30 - Minamino, T., and R. M. Macnab. 2000. Domain structure of Salmonella FlhB, a flagellar export component responsible for substrate specificity switching. J. Bacteriol. 182:4906-4914.[Abstract/Free Full Text]
31 - Minamino, T., and R. M. MacNab. 2000. Interactions among components of the Salmonella flagellar export apparatus and its substrates. Mol. Microbiol. 35:1052-1064.[CrossRef][Medline]
32 - Nilles, M. L., A. W. Williams, E. Skrzypek, and S. C. Straley. 1997. Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response. J. Bacteriol. 179:1307-1316.[Abstract/Free Full Text]
33 - Nordfelth, R., and H. Wolf-Watz. 2001. YopB of Yersinia enterocolitica is essential for YopE translocation. Infect. Immun. 69:3516-3518.[Abstract/Free Full Text]
34 - Patterson-Delafield, J., R. J. Martinez, B. A. Stocker, and S. Yamaguchi. 1973. A new fla gene in Salmonella typhimuriumflaRand its mutant phenotype-superhooks. Arch. Mikrobiol. 90:107-120.[CrossRef][Medline]
35 - Payne, P. L., and S. C. Straley. 1999. YscP of Yersinia pestis is a secreted component of the Yop secretion system. J. Bacteriol. 181:2852-2862.[Abstract/Free Full Text]
36 - Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestisetiologic agent of plague. Clin. Microbiol Rev. 10:35-66.[Abstract]
37 - Pettersson, J., R. Nordfelth, E. Dubinina, T. Bergman, M. Gustafsson, K. E. Magnusson, and H. Wolf-Watz. 1996. Modulation of virulence factor expression by pathogen target cell contact. Science 273:1231-1233.[Abstract]
38 - Rosqvist, R., I. Bolin, and H. Wolf-Watz. 1988. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect. Immun. 56:2139-2143.[Abstract/Free Full Text]
39 - Rosqvist, R., A. Forsberg, M. Rimpilainen, T. Bergman, and H. Wolf-Watz. 1990. The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol. Microbiol. 4:657-667.[Medline]
40 - Rosqvist, R., A. Forsberg, and H. Wolf-Watz. 1991. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59:4562-4569.[Abstract/Free Full Text]
41 - Russmann, H., T. Kubori, J. Sauer, and J. E. Galan. 2002. Molecular and functional analysis of the type III secretion signal of the Salmonella enterica InvJ protein. Mol. Microbiol. 46:769-779.[CrossRef][Medline]
42 - Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
43 - Simon, R., U. Preifer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Bio/Technology. 1:784-791.[CrossRef]
44 - Simonet, M., S. Richard, and P. Berche. 1990. Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect. Immun. 58:841-845.[Abstract/Free Full Text]
45 - Sory, M. P., and G. R. Cornelis. 1994. Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14:583-594.[Medline]
46 - Stainier, I., S. Bleves, C. Josenhans, L. Karmani, C. Kerbourch, I. Lambermont, S. Totemeyer, A. Boyd, and G. R. Cornelis. 2000. YscP, a Yersinia protein required for Yop secretion that is surface exposed, and released in low Ca2+. Mol. Microbiol. 37:1005-1018.[CrossRef][Medline]
47 - Studier, F. W., and B. A. Moffatt. 1986. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130.[CrossRef][Medline]
48 - Tamano, K., S. Aizawa, E. Katayama, T. Nonaka, S. Imajoh-Ohmi, A. Kuwae, S. Nagai, and C. Sasakawa. 2000. Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors. EMBO J. 19:3876-3887.[CrossRef][Medline]
49 - Tamano, K., E. Katayama, T. Toyotome, and C. Sasakawa. 2002. Shigella Spa32 is an essential secretory protein for functional type III secretion machinery and uniformity of its needle length. J. Bacteriol. 184:1244-1252.[Abstract/Free Full Text]
50 - Williams, A. W., and S. C. Straley. 1998. YopD of Yersinia pestis plays a role in negative regulation of the low-calcium response in addition to its role in translocation of Yops. J. Bacteriol. 180:350-358.[Abstract/Free Full Text]
51 - Williams, A. W., S. Yamaguchi, F. Togashi, S.-I. Aizawa, I. Kawagishi, and R. M. Macnab. 1996. Mutations in fliK and flhB affecting flagellar hook and filament assembly in Salmonella typhimurium. J. Bacteriol. 178:2960-2970.[Abstract/Free Full Text]
52 - Visser, L. G., A. Annema, and R. van Furth. 1995. Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect. Immun. 63:2570-2575.[Abstract]
53 - Von Pawel-Rammingen, U., M. V. Telepnev, G. Schmidt, K. Aktories, H. Wolf-Watz, and R. Rosqvist. 2000. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol. Microbiol. 36:737-748.[CrossRef][Medline]
Journal of Bacteriology, April 2003, p. 2259-2266, Vol. 185, No. 7
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.7.2259-2266.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bjornfot, A.-C., Lavander, M., Forsberg, A., Wolf-Watz, H.
(2009). Autoproteolysis of YscU of Yersinia pseudotuberculosis Is Important for Regulation of Expression and Secretion of Yop Proteins. J. Bacteriol.
191: 4259-4267
[Abstract]
[Full Text]
-
Morello, J. E., Collmer, A.
(2009). Pseudomonas syringae HrpP Is a Type III Secretion Substrate Specificity Switch Domain Protein That Is Translocated into Plant Cells but Functions Atypically for a Substrate-Switching Protein. J. Bacteriol.
191: 3120-3131
[Abstract]
[Full Text]
-
Riordan, K. E., Sorg, J. A., Berube, B. J., Schneewind, O.
(2008). Impassable YscP Substrates and Their Impact on the Yersinia enterocolitica Type III Secretion Pathway. J. Bacteriol.
190: 6204-6216
[Abstract]
[Full Text]
-
Wood, S. E., Jin, J., Lloyd, S. A.
(2008). YscP and YscU Switch the Substrate Specificity of the Yersinia Type III Secretion System by Regulating Export of the Inner Rod Protein YscI. J. Bacteriol.
190: 4252-4262
[Abstract]
[Full Text]
-
Carlsson, K. E., Liu, J., Edqvist, P. J., Francis, M. S.
(2007). Extracytoplasmic-Stress-Responsive Pathways Modulate Type III Secretion in Yersinia pseudotuberculosis. Infect. Immun.
75: 3913-3924
[Abstract]
[Full Text]
-
Sorg, J. A., Blaylock, B., Schneewind, O.
(2006). Secretion signal recognition by YscN, the Yersinia type III secretion ATPase. Proc. Natl. Acad. Sci. USA
103: 16490-16495
[Abstract]
[Full Text]
-
Kenjale, R., Wilson, J., Zenk, S. F., Saurya, S., Picking, W. L., Picking, W. D., Blocker, A.
(2005). The Needle Component of the Type III Secreton of Shigella Regulates the Activity of the Secretion Apparatus. J. Biol. Chem.
280: 42929-42937
[Abstract]
[Full Text]
-
Ferris, H. U., Furukawa, Y., Minamino, T., Kroetz, M. B., Kihara, M., Namba, K., Macnab, R. M.
(2005). FlhB Regulates Ordered Export of Flagellar Components via Autocleavage Mechanism. J. Biol. Chem.
280: 41236-41242
[Abstract]
[Full Text]
-
Ghosh, P.
(2004). Process of Protein Transport by the Type III Secretion System. Microbiol. Mol. Biol. Rev.
68: 771-795
[Abstract]
[Full Text]
-
Journet, L., Agrain, C., Broz, P., Cornelis, G. R.
(2003). The Needle Length of Bacterial Injectisomes Is Determined by a Molecular Ruler. Science
302: 1757-1760
[Abstract]
[Full Text]